CAS 1062444-54-5

1V209

CAS : 1062444-54-5

1V209

Degré de pureté : ≥98%

Masse moléculaire : 359.34g/mol

Ref: 54-BUP04544

4-((6-Amino-2-(2-Methoxyethoxy)-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Benzoic Acid

CAS : 1062444-54-5

4-((6-Amino-2-(2-Methoxyethoxy)-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Benzoic Acid

Degré de pureté : 98%

Masse moléculaire : 359.34g/mol

Ref: 54-OR1023217

1V209

CAS : 1062444-54-5

1V209 (TLR7 agonist T7) is a Toll-like receptor 7 (TLR7) agonist and has anti-tumor effects.

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : 99.61%

Couleur et forme : Solid

Masse moléculaire : 359.34

Ref: TM-T8316

4-((6-AMINO-2-(2-METHOXYETHOXY)-8-OXO-7,8-DIHYDRO-9H-PURIN-9-YL)METHYL)BENZOIC ACID

CAS : 1062444-54-5

Degré de pureté : 95%

Masse moléculaire : 359.3420105

Ref: 10-F840887

1V209

CAS : 1062444-54-5

1V209 is a vaccine adjuvant that has been shown to stimulate an antitumor response. It is a molecule that binds to toll-like receptor 4 (TLR4) on tumor cells, stimulating TLR4-mediated signaling pathways, which induces the production of death proteins. 1V209 also upregulates PD-L1 expression in tumor cells and activates the immune system to target and kill cancer cells. 1V209 may be used as a cancer therapy or as a vaccine adjuvant against infectious diseases such as hepatitis B, hepatitis C, and human immunodeficiency virus.

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : Min. 95%

Masse moléculaire : 359.34 g/mol

Ref: 3D-MSB44454